Sentence examples for new formulary from inspiring English sources

We conducted an observational study to determine the impact of this new formulary restriction policy on antimicrobial prescription rates as well as any clinical and economic consequences.

We conducted an observational study to determine the impact of this new formulary restriction policy on antimicrobial prescription rates as well as any clinical consequences.

Acknowledging that traditional prior authorization was likely infeasible, a new formulary restriction was developed (termed "optional special authorization" (OSA)) in conjunction with changes to prescribing restrictions for quinolone antibiotics.

Despite the addition of two new quinolone antibiotics to the formulary, we found that there was no change in the use of quinolones after implementation of a new formulary restriction policy for outpatients with common outpatient infections.

On November 15 , 2005 AHW established a new formulary restriction policy for quinolones (entitled "optional special authorization" (OSA) (Additional file 1)) where physicians could voluntarily enroll and become a designated quinolone prescriber, and at the same time, AHW added two new quinolones (gatifloxacin and moxifloxacin) to the formulary.

The introduction of new agents on formulary may provide an improvement in clinical options but often further complicates prescribing practice.

The "arm's length" rules on these transfers are in desperate need of an overhaul, though the OECD rejects the idea of replacing them with a brand new approach, such as "formulary apportionment", advocated by some NGOs (it would allocate profits according to a formula based on the location of sales, employees or other such metrics).Thinking has come a long way in a short time.

Not adding new drugs to a formulary is seen as a mechanism to keep drug costs down.

Approval of a new drug for the formulary is made by the Inter Institutional Commission.

Although European Society of Medical Oncology ESMOO) recommends axitinib and pazopanib for second line treatment of renal cell carcinoma [ 13], current recession and austerity measures impede introduction of new products in the formulary.

For example, when a managed care plan considers whether or not to include a new drug on their formulary, what matters is how much they have to pay for the drug and what the potential benefits are, not how many billions of dollars were spent developing the drug.